Genomtec S.A. (GMT) — Financial Flexibility Index
Genomtec S.A. (GMT) has a Financial Flexibility Index of -0.30x as of March 2026. Free cash flow of zł-1.81 Million (operating CF zł-1.84 Million minus capex zł27.00K) represents 0% of total liabilities (zł6.01 Million). Check Genomtec S.A. PP&E and investment ratio to assess the company's strategic physical and investment asset allocation.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Genomtec S.A. Financial Flexibility Index (2019–2024)
Historical Financial Flexibility Index trend for Genomtec S.A. across 6 annual periods. See GMT working capital ratio to evaluate short-term liquidity relative to the company's equity base.
Annual Financial Flexibility Index for Genomtec S.A. (2019–2024)
Year-by-year free cash flow to debt coverage for Genomtec S.A.. For the full company profile including market capitalisation, see Genomtec S.A. market cap and net worth.
| Year | Flexibility Index | Free Cash Flow (PLN) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2024 | -0.71x | zł-6.66 Million | zł-6.72 Million | zł9.44 Million | ▼ -22.2% |
| 2023 | -0.58x | zł-4.42 Million | zł-7.95 Million | zł7.67 Million | ▼ -825.7% |
| 2022 | 0.08x | zł546.00K | zł-3.79 Million | zł6.87 Million | ▲ +105.2% |
| 2021 | -1.53x | zł-5.32 Million | zł-5.53 Million | zł3.48 Million | ▼ -15.1% |
| 2020 | -1.33x | zł-2.39 Million | zł-2.52 Million | zł1.80 Million | ▼ -98.7% |
| 2019 | -0.67x | zł-1.20 Million | zł-1.69 Million | zł1.80 Million | — |